[Advances of Claudin6-targeting drugs in cancer therapy].

Saved in:
Bibliographic Details
Title: [Advances of Claudin6-targeting drugs in cancer therapy].
Authors: Li G; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China., Bi Y; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China., Hao R; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China., Zheng X; Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd, Tianjin 300402, China., Wang G; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China., Li J; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China., Wang P; Tasly Biopharmaceuticals Co., Ltd, Tianjin 300402, China.
Source: Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Sheng Wu Gong Cheng Xue Bao] 2023 Apr 25; Vol. 39 (4), pp. 1304-1313.
Publication Type: English Abstract; Journal Article
Journal Info: Publisher: Ke xue chu ban she Country of Publication: China NLM ID: 9426463 Publication Model: Print Cited Medium: Internet ISSN: 1872-2075 (Electronic) Linking ISSN: 10003061 NLM ISO Abbreviation: Sheng Wu Gong Cheng Xue Bao Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first